Developer docs
API playgroundTry for free, no card

Search company profiles

PharmAlliance

Full company profile

uuid000tkfw

Namestring
PharmAlliance
Legal namestring
PharmAlliance
Company typeenum
Private
Founded yearint
2000
Descriptiontext

PharmAlliance is an independent, privately-held professional consulting firm headquartered in Ahmedabad, India, founded in January 2000. It serves pharmaceutical, biopharmaceutical, active pharmaceutical ingredient (API), medical device, and excipient manufacturers — primarily enterprise clients seeking to enter or maintain presence in regulated markets including the USA, Canada, Europe, Australia, South Africa, and Asia. The firm states it has served clients across 30+ countries and operates from a small core team (1–10 employees) led by CEO Asaf Shamsi, who has 30+ years of regulatory and consulting experience.

The company's service portfolio is organized into seven core lines: facility design and project services (cGXP-compliant manufacturing, testing, and R&D facilities); international regulatory affairs (submissions to FDA, TPD, EMEA, EDQM, EU National Authorities, TGA, MCC, and WHO); quality systems development; cGXP and due diligence audits; pre-clinical, clinical, and bioequivalence study support (via a CRO partner network); customized training and education; and business development consulting including sponsor identification and CRAMS outsourcing. Specialized submission services include DMF/EDMF, CEP/COS, and ANDA/ANDS/Abridged MAA preparation. The firm has no proprietary technology platform; its product is human expertise, supported by an international network of CROs, architectural/engineering partners, and industry relationships (including historical ties with CII and IIMA in Ahmedabad).

PharmAlliance monetizes through professional services fees quoted per engagement, with customized packages. It markets primarily via its website, industry articles, seminars, and a referral-driven network. No public financials, funding, or ownership changes are disclosed, and there is no evidence of AI tooling or software product lines — the business is a pure-play knowledge consultancy.

Short descriptiontext

PharmAlliance is a privately-held, India-based boutique consultancy serving pharmaceutical, biopharmaceutical, API, and medical device manufacturers with cGXP facility design, international regulatory affairs, quality systems, audits, and business development services across 30+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAhmedabad, India
HQ citystring
Ahmedabad
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical regulatory consulting, cGXP compliance audits, facility design consulting, drug master file services, pharmaceutical business development
Industry3 codes
PRIMARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYEDAOAJAO
Clinical Research Support (CRC/CTA)
Education/Vocational, Technical & Trade Education/Healthcare Allied & Clinical Support Training
NAICS code2 codes
  • Management Consulting Services54161
  • Other Management Consulting Services541618
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Pharmaceutical Regulatory Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Regulatory Affairs Consulting
TypeProfessional Services
Description

Professional consulting services for regulatory submissions, compliance management, cGXP audits, and regulatory approvals for FDA, TPD, EMEA, EDQM, EU National Authorities, TGA, MCC, and WHO. Services include preparation and handling of DMF/EDMF, CEP/COS, ANDA/ANDS, Abridged MAA, and other regulatory submissions.

pharmalliance.com
2Facility Design and Project Services
TypeProfessional Services
Description

Consulting for conceptualization, design, and development of state-of-the-art manufacturing, testing, and R&D facilities conforming to international cGXP (GMP, GLP, GCP) norms. Includes modernization of existing facilities.

pharmalliance.com
3Business Development Consulting
TypeProfessional Services
Description

Strategic planning, international patent screening, product/market selection, sponsor identification, market penetration strategies, and assistance with contract manufacturing, testing, research arrangements, product licensing, and sales/distribution arrangements.

pharmalliance.com
4Training and Education
TypeProfessional Services
Description

Customized training programs, workshops, and seminars covering regulatory affairs, compliance management, GMP, GLP, GCP, validation, and other pharmaceutical industry topics.

pharmalliance.com
5Preclinical/Clinical/Bioequivalence Studies Support
TypeProfessional Services
Description

Support services for studies across the entire preclinical and clinical research spectrum including Phase I, II, and III trials as well as bioequivalence studies for European and North American markets.

pharmalliance.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

PharmAlliance is an independent professional consulting firm providing end-to-end consulting services for the pharmaceutical, biopharmaceutical, API, medical device, and allied industries. Core offerings include international regulatory affairs (DMF/EDMF, CEP/COS, ANDA/ANDS, MAA submissions to FDA, TPD, EMEA, EDQM, TGA, MCC), cGXP-compliant facility design and project services, quality systems development, cGXP and due diligence audits, pre-clinical/clinical/bioequivalence study support, business development consulting, and customized training programs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Comprehensive support for regulatory submissions in CTD, eCTD, or alternative (national) formats
Product overview1 text field

PharmAlliance is an independent professional consulting firm providing comprehensive, end-to-end consulting services for the pharmaceutical, biopharmaceutical, API, medical device, and allied industries. The company operates as a service-based consultancy rather than a software product company, offering integrated services across facility design and development, international regulatory affairs, quality systems, auditing, clinical research support, training, and business development. The core service portfolio includes facility design conforming to cGXP norms, preparation and handling of regulatory submissions (DMF/EDMF, CEP, ANDA/ANDS/MAA), quality systems development, cGXP audits, pre-clinical/clinical/bioequivalence study support, customized training programs, and international business development consulting including sponsor identification and outsourcing arrangements. The company maintains an extensive database and worldwide contacts to facilitate market entry into regulated markets including USA, Canada, Europe, Australia, and South Africa.

Product and service13 records
1Facility Design and Development / Project Services
CategoryFacility Design Consulting
Description

Consulting service for pharmaceutical companies that involves conceptualizing and designing state-of-the-art manufacturing, testing, and R&D facilities conforming to international cGXP (GMP, GLP, GCP) norms, including new project implementation and modernization of existing facilities.

2International Regulatory Affairs
CategoryRegulatory Affairs Consulting
Description

End-to-end regulatory affairs service for pharmaceutical and biopharmaceutical clients, preparing and handling regulatory submissions to major agencies including FDA (USA), TPD (Canada), EMEA, EDQM, EU National Authorities (MHRA, BfArM), TGA (Australia), and MCC (South Africa).

3Quality Systems Development
CategoryQuality and Compliance Consulting
Description

Service that develops and implements pharmaceutical quality systems, including manufacturing/control systems, SOPs, and related documentation, to achieve full cGXP (GMP, GLP, GCP) compliance.

4cGXP and Due Diligence Audits
CategoryAudit and Compliance Services
Description

Audit service that conducts cGXP audits of clients' own facilities to assess compliance, as well as cGXP and due diligence audits of contract or outsourcing facilities on behalf of clients to monitor them for compliance.

5Pre-Clinical, Clinical and Bioequivalence Studies Support
CategoryClinical Research Support
Description

Support service for studies across the entire pre-clinical and clinical research spectrum, including Phase I, II, and III trials as well as bioequivalence studies, with delivery for European and North American markets facilitated through reputed CROs.

6Training and Education
CategoryTraining Services
Description

Customized training programs, workshops, and seminars covering regulatory affairs, compliance management, manufacturing operations, validation, and clinical research, tailored to specific client needs and delivered for all levels of management.

7Business Development Consulting
CategoryBusiness Development Consulting
Description

Strategic consulting service assisting clients with planning for international business development, including international patent screening, product/market selection, sponsor identification, feasibility studies, market penetration strategies, and contract manufacturing, testing, research, product licensing, and sales/distribution arrangements.

8Outsourcing Arrangements (CRAMS)
CategoryOutsourcing and CRAMS Consulting
Description

Service that assists clients in locating contract manufacturing, testing, or research facilities and joint venture partners for outsourcing in Asian markets, and conducts due diligence and cGXP audits of potential collaborators on behalf of clients.

9Drug Master Files (DMF/EDMF) Services
CategoryRegulatory Submission Services
Description

Specialized regulatory service that prepares and files US, Canadian, and European Drug Master Files for APIs, packaging materials, and excipients, including guidance on ICH Q7/US FDA/EU/TPD cGMP compliance.

10Certificate of Suitability (CEP/COS) Services
CategoryRegulatory Submission Services
Description

Specialized regulatory service that facilitates certification of APIs and excipients by the European Directorate for the Quality of Medicines (EDQM), including preparation of application dossiers, quality summaries, and EDQM liaison.

11ANDA / ANDS / Abridged MAA Services
CategoryRegulatory Submission Services
Description

Specialized regulatory service providing complete guidance for preparation and submission of Abbreviated New Drug Applications (USA), Abbreviated New Drug Submissions (Canada), and Abridged Marketing Authorization Applications (Europe) for generic pharmaceuticals.

12Sponsor Identification Services
CategoryBusiness Development Services
Description

Specialized service that identifies dosage form manufacturers (sponsors) who can trigger regulatory review of Drug Master Files and guide products through regulatory systems in regulated markets such as the USA, Canada, and Europe.

13Regulatory Affairs Representation
CategoryRegulatory Representation Services
Description

Support service providing regulatory affairs representation and liaison services with regulatory agencies including FDA, TPD, EU authorities, EDQM, and regulatory agents for submissions and inspections.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1Confederation of Indian Industry (CII)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2000-08-17
Description

PharmAlliance co-organized a seminar on 'Market Penetration and Regulatory Approvals in Europe and USA' with CII Gujarat at the Indian Institute of Management, Ahmedabad (IIMA) on October 25, 2000. The seminar aimed to provide a platform for Indian Pharmaceutical Industry to interact with top-level industry and regulatory experts from India and abroad.

pharmalliance.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2000-08-17
Description

Host venue partner for the CII-PharmAlliance seminar on Market Penetration and Regulatory Approvals. The seminar featured speakers from Zydus-Cadila, Wockhardt, Intas Pharmaceuticals, and international regulatory experts.

3Contract Research Organizations (CROs) Network
Strategic tierCoreTypeStrategic or Co-development Partner
Description

PharmAlliance has links with reputed CROs in USA, Canada, Europe (including Eastern Europe), and India. The company facilitates access to comprehensive resources, expertise, and experience of such reputed CROs for preclinical and clinical studies including Phase I, II, and III trials as well as bioequivalence studies.

pharmalliance.com
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

PharmAlliance has partnered with architectural and engineering firms for facility design and development projects. The company joined hands with reputed architectural and engineering partners as mentioned in PharmaBiz.com coverage.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global CRO and regulatory consulting firm offering clinical trial, regulatory strategy, and market access services to pharma and biopharma. A broad-incumbent competitor to PharmAlliance on regulatory affairs and clinical study support.

TypeBroad incumbent
Description

Major global CRO providing clinical, regulatory, and bioequivalence services across pharma and medical devices. Overlaps with PharmAlliance on pre-clinical/clinical/bioequivalence study support, though at a vastly larger scale and broader scope.

TypeDirect peer
Description

Global regulatory, compliance, and quality consulting firm serving pharma, biopharma, and medical device manufacturers. Competes directly with PharmAlliance on regulatory submissions, GxP audits, quality systems, and facility compliance consulting.

TypeDirect peer
Description

Hyderabad-headquartered regulatory affairs and compliance consulting firm serving pharmaceutical, biopharma, and medical device clients across global regulated markets. Direct competitor to PharmAlliance in international DMF, CEP, ANDA, and quality systems services, with a comparable India-based delivery model.

TypeDirect peer
Description

Large, now Cencora-owned regulatory affairs, quality, and pharmacovigilance consultancy serving global pharmaceutical companies. Overlaps directly with PharmAlliance on regulatory submissions, CMC, GxP compliance, and global market entry support.

TypeBroad incumbent
Description

Global clinical research, regulatory, and commercial services giant serving pharma, biotech, and medical device manufacturers worldwide. A much larger, broad-incumbent alternative that competes on regulatory and clinical study support services that overlap with PharmAlliance's offering.

TypeDirect peer
Description

Regulatory affairs consulting and technology firm helping life sciences companies with eCTD submissions, regulatory strategy, and lifecycle management. Comparable to PharmAlliance in regulatory affairs depth but with stronger technology-enabled submission tooling.

8Navitas Life Sciences
TypeDirect peer
Description

India-rooted (now backed by TAKE Solutions) provider of regulatory, clinical, and pharmacovigilance services to pharma and medical device companies. Overlaps with PharmAlliance on regulatory affairs, clinical study support, and bioequivalence services for regulated markets.

TypeDirect peer
Description

Specialist regulatory affairs and quality compliance consultancy serving pharma, biopharma, and medical device companies across Europe, the US, and emerging markets. Direct overlap with PharmAlliance on international regulatory submissions, GxP compliance, and facility/quality systems work.

10Skillmine Technology Consulting
TypeRegional player
Description

India-headquartered consulting firm offering technology and advisory services to healthcare and life sciences clients. Tangentially comparable in serving pharma clients from India, but with a technology rather than regulatory affairs focus.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PharmAlliance

Pharmaceutical Regulatory Consultingpharmalliance.com

PharmAlliance is a privately-held, India-based boutique consultancy serving pharmaceutical, biopharmaceutical, API, and medical device manufacturers with cGXP facility design, international regulatory affairs, quality systems, audits, and business development services across 30+ countries.

What PharmAlliance does

PharmAlliance is an independent, privately-held professional consulting firm headquartered in Ahmedabad, India, founded in January 2000. It serves pharmaceutical, biopharmaceutical, active pharmaceutical ingredient (API), medical device, and excipient manufacturers — primarily enterprise clients seeking to enter or maintain presence in regulated markets including the USA, Canada, Europe, Australia, South Africa, and Asia. The firm states it has served clients across 30+ countries and operates from a small core team (1–10 employees) led by CEO Asaf Shamsi, who has 30+ years of regulatory and consulting experience.

The company's service portfolio is organized into seven core lines: facility design and project services (cGXP-compliant manufacturing, testing, and R&D facilities); international regulatory affairs (submissions to FDA, TPD, EMEA, EDQM, EU National Authorities, TGA, MCC, and WHO); quality systems development; cGXP and due diligence audits; pre-clinical, clinical, and bioequivalence study support (via a CRO partner network); customized training and education; and business development consulting including sponsor identification and CRAMS outsourcing. Specialized submission services include DMF/EDMF, CEP/COS, and ANDA/ANDS/Abridged MAA preparation. The firm has no proprietary technology platform; its product is human expertise, supported by an international network of CROs, architectural/engineering partners, and industry relationships (including historical ties with CII and IIMA in Ahmedabad).

PharmAlliance monetizes through professional services fees quoted per engagement, with customized packages. It markets primarily via its website, industry articles, seminars, and a referral-driven network. No public financials, funding, or ownership changes are disclosed, and there is no evidence of AI tooling or software product lines — the business is a pure-play knowledge consultancy.

PharmAlliance firmographics

Firmographics
Name
PharmAlliance
Legal name
PharmAlliance
Website
https://pharmalliance.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
1–10 employees
Short description
PharmAlliance is a privately-held, India-based boutique consultancy serving pharmaceutical, biopharmaceutical, API, and medical device manufacturers with cGXP facility design, international regulatory affairs, quality systems, audits, and business development services across 30+ countries.
Ownership category
akta.pro rank

PharmAlliance industry classification

Industry
Product category
Pharmaceutical Regulatory Consulting
NAICS
Management Consulting Services (54161), Other Management Consulting Services (541618)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYEDAOAJAO
Clinical Research Support (CRC/CTA)
Education/Vocational, Technical & Trade Education/Healthcare Allied & Clinical Support Training

Keywords

  • Pharmaceutical regulatory consulting
  • CGXP compliance audits
  • Facility design consulting
  • Drug master file services
  • Pharmaceutical business development

Where PharmAlliance is headquartered

Location

Headquarters

HQ city
Ahmedabad
HQ country
India
HQ region
Asia

Offices1 record

Markets served

PharmAlliance business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Regulatory Affairs Consulting: Professional consulting services for regulatory submissions, compliance management, cGXP audits, and regulatory approvals for FDA, TPD, EMEA, EDQM, EU National Authorities, TGA, MCC, and WHO. Services include preparation and handling of DMF/EDMF, CEP/COS, ANDA/ANDS, Abridged MAA, and other regulatory submissions.
  2. Facility Design and Project Services: Consulting for conceptualization, design, and development of state-of-the-art manufacturing, testing, and R&D facilities conforming to international cGXP (GMP, GLP, GCP) norms. Includes modernization of existing facilities.
  3. Business Development Consulting: Strategic planning, international patent screening, product/market selection, sponsor identification, market penetration strategies, and assistance with contract manufacturing, testing, research arrangements, product licensing, and sales/distribution arrangements.
  4. Training and Education: Customized training programs, workshops, and seminars covering regulatory affairs, compliance management, GMP, GLP, GCP, validation, and other pharmaceutical industry topics.
  5. Preclinical/Clinical/Bioequivalence Studies Support: Support services for studies across the entire preclinical and clinical research spectrum including Phase I, II, and III trials as well as bioequivalence studies for European and North American markets.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

PharmAlliance product offering

Product offering

Core offering

PharmAlliance is an independent professional consulting firm providing end-to-end consulting services for the pharmaceutical, biopharmaceutical, API, medical device, and allied industries. Core offerings include international regulatory affairs (DMF/EDMF, CEP/COS, ANDA/ANDS, MAA submissions to FDA, TPD, EMEA, EDQM, TGA, MCC), cGXP-compliant facility design and project services, quality systems development, cGXP and due diligence audits, pre-clinical/clinical/bioequivalence study support, business development consulting, and customized training programs.

Product overview

PharmAlliance is an independent professional consulting firm providing comprehensive, end-to-end consulting services for the pharmaceutical, biopharmaceutical, API, medical device, and allied industries. The company operates as a service-based consultancy rather than a software product company, offering integrated services across facility design and development, international regulatory affairs, quality systems, auditing, clinical research support, training, and business development. The core service portfolio includes facility design conforming to cGXP norms, preparation and handling of regulatory submissions (DMF/EDMF, CEP, ANDA/ANDS/MAA), quality systems development, cGXP audits, pre-clinical/clinical/bioequivalence study support, customized training programs, and international business development consulting including sponsor identification and outsourcing arrangements. The company maintains an extensive database and worldwide contacts to facilitate market entry into regulated markets including USA, Canada, Europe, Australia, and South Africa.

Differentiator

Problem solved

Functional benefit

Products and services

  • Facility Design and Development / Project Services Consulting service for pharmaceutical companies that involves conceptualizing and designing state-of-the-art manufacturing, testing, and R&D facilities conforming to international cGXP (GMP, GLP, GCP) norms, including new project implementation and modernization of existing facilities.
  • International Regulatory Affairs End-to-end regulatory affairs service for pharmaceutical and biopharmaceutical clients, preparing and handling regulatory submissions to major agencies including FDA (USA), TPD (Canada), EMEA, EDQM, EU National Authorities (MHRA, BfArM), TGA (Australia), and MCC (South Africa).
  • Quality Systems Development Service that develops and implements pharmaceutical quality systems, including manufacturing/control systems, SOPs, and related documentation, to achieve full cGXP (GMP, GLP, GCP) compliance.
  • cGXP and Due Diligence Audits Audit service that conducts cGXP audits of clients' own facilities to assess compliance, as well as cGXP and due diligence audits of contract or outsourcing facilities on behalf of clients to monitor them for compliance.
  • Pre-Clinical, Clinical and Bioequivalence Studies Support Support service for studies across the entire pre-clinical and clinical research spectrum, including Phase I, II, and III trials as well as bioequivalence studies, with delivery for European and North American markets facilitated through reputed CROs.
  • Training and Education Customized training programs, workshops, and seminars covering regulatory affairs, compliance management, manufacturing operations, validation, and clinical research, tailored to specific client needs and delivered for all levels of management.
  • Business Development Consulting Strategic consulting service assisting clients with planning for international business development, including international patent screening, product/market selection, sponsor identification, feasibility studies, market penetration strategies, and contract manufacturing, testing, research, product licensing, and sales/distribution arrangements.
  • Outsourcing Arrangements (CRAMS) Service that assists clients in locating contract manufacturing, testing, or research facilities and joint venture partners for outsourcing in Asian markets, and conducts due diligence and cGXP audits of potential collaborators on behalf of clients.
  • Drug Master Files (DMF/EDMF) Services Specialized regulatory service that prepares and files US, Canadian, and European Drug Master Files for APIs, packaging materials, and excipients, including guidance on ICH Q7/US FDA/EU/TPD cGMP compliance.
  • Certificate of Suitability (CEP/COS) Services Specialized regulatory service that facilitates certification of APIs and excipients by the European Directorate for the Quality of Medicines (EDQM), including preparation of application dossiers, quality summaries, and EDQM liaison.
  • ANDA / ANDS / Abridged MAA Services Specialized regulatory service providing complete guidance for preparation and submission of Abbreviated New Drug Applications (USA), Abbreviated New Drug Submissions (Canada), and Abridged Marketing Authorization Applications (Europe) for generic pharmaceuticals.
  • Sponsor Identification Services Specialized service that identifies dosage form manufacturers (sponsors) who can trigger regulatory review of Drug Master Files and guide products through regulatory systems in regulated markets such as the USA, Canada, and Europe.
  • Regulatory Affairs Representation Support service providing regulatory affairs representation and liaison services with regulatory agencies including FDA, TPD, EU authorities, EDQM, and regulatory agents for submissions and inspections.

Quantifiable outcome

  • Comprehensive support for regulatory submissions in CTD, eCTD, or alternative (national) formats

Companies that use PharmAlliance

Customer profile

Segments5 records

Ideal customer profiles4 records

PharmAlliance technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

PharmAlliance partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Confederation of Indian Industry (CII)coreStrategic or Co-development Partner · 17 August 2000PharmAlliance co-organized a seminar on 'Market Penetration and Regulatory Approvals in Europe and USA' with CII Gujarat at the Indian Institute of Management, Ahmedabad (IIMA) on October 25, 2000. The seminar aimed to provide a platform for Indian Pharmaceutical Industry to interact with top-level industry and regulatory experts from India and abroad.
  • Indian Institute of Management Ahmedabad (IIMA)coreStrategic or Co-development Partner · 17 August 2000Host venue partner for the CII-PharmAlliance seminar on Market Penetration and Regulatory Approvals. The seminar featured speakers from Zydus-Cadila, Wockhardt, Intas Pharmaceuticals, and international regulatory experts.
  • Contract Research Organizations (CROs) NetworkcoreStrategic or Co-development PartnerPharmAlliance has links with reputed CROs in USA, Canada, Europe (including Eastern Europe), and India. The company facilitates access to comprehensive resources, expertise, and experience of such reputed CROs for preclinical and clinical studies including Phase I, II, and III trials as well as bioequivalence studies.
  • Architectural and Engineering AssociatesminorImplementation/ SI/ Consulting PartnerPharmAlliance has partnered with architectural and engineering firms for facility design and development projects. The company joined hands with reputed architectural and engineering partners as mentioned in PharmaBiz.com coverage.

Scale indicators2 records

Recent moves4 records

Expansion highlights3 records

PharmAlliance competitors and assessment

Company assessment

Broad incumbents

  • Parexel International: Global CRO and regulatory consulting firm offering clinical trial, regulatory strategy, and market access services to pharma and biopharma. A broad-incumbent competitor to PharmAlliance on regulatory affairs and clinical study support.
  • ICON plc: Major global CRO providing clinical, regulatory, and bioequivalence services across pharma and medical devices. Overlaps with PharmAlliance on pre-clinical/clinical/bioequivalence study support, though at a vastly larger scale and broader scope.
  • IQVIA: Global clinical research, regulatory, and commercial services giant serving pharma, biotech, and medical device manufacturers worldwide. A much larger, broad-incumbent alternative that competes on regulatory and clinical study support services that overlap with PharmAlliance's offering.

Direct peers

  • ProPharma Group: Global regulatory, compliance, and quality consulting firm serving pharma, biopharma, and medical device manufacturers. Competes directly with PharmAlliance on regulatory submissions, GxP audits, quality systems, and facility compliance consulting.
  • Freyr Solutions: Hyderabad-headquartered regulatory affairs and compliance consulting firm serving pharmaceutical, biopharma, and medical device clients across global regulated markets. Direct competitor to PharmAlliance in international DMF, CEP, ANDA, and quality systems services, with a comparable India-based delivery model.
  • PharmaLex (Cencora): Large, now Cencora-owned regulatory affairs, quality, and pharmacovigilance consultancy serving global pharmaceutical companies. Overlaps directly with PharmAlliance on regulatory submissions, CMC, GxP compliance, and global market entry support.
  • Cunesoft: Regulatory affairs consulting and technology firm helping life sciences companies with eCTD submissions, regulatory strategy, and lifecycle management. Comparable to PharmAlliance in regulatory affairs depth but with stronger technology-enabled submission tooling.
  • Navitas Life Sciences: India-rooted (now backed by TAKE Solutions) provider of regulatory, clinical, and pharmacovigilance services to pharma and medical device companies. Overlaps with PharmAlliance on regulatory affairs, clinical study support, and bioequivalence services for regulated markets.
  • Arriello Group: Specialist regulatory affairs and quality compliance consultancy serving pharma, biopharma, and medical device companies across Europe, the US, and emerging markets. Direct overlap with PharmAlliance on international regulatory submissions, GxP compliance, and facility/quality systems work.

Regional players

  • Skillmine Technology Consulting: India-headquartered consulting firm offering technology and advisory services to healthcare and life sciences clients. Tangentially comparable in serving pharma clients from India, but with a technology rather than regulatory affairs focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

PharmAlliance social profiles

Digital presence

PharmAlliance financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PharmAlliance leadership team

Management profile

Number of profiles

Profiles2 records

PharmAlliance funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PharmAlliance M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharmAlliance

What does PharmAlliance do?

PharmAlliance is an independent professional consulting firm providing end-to-end consulting services for the pharmaceutical, biopharmaceutical, API, medical device, and allied industries. Core offerings include international regulatory affairs (DMF/EDMF, CEP/COS, ANDA/ANDS, MAA submissions to FDA, TPD, EMEA, EDQM, TGA, MCC), cGXP-compliant facility design and project services, quality systems development, cGXP and due diligence audits, pre-clinical/clinical/bioequivalence study support, business development consulting, and customized training programs.

Is PharmAlliance a public or private company?

PharmAlliance is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was PharmAlliance founded?

PharmAlliance was founded in 2000. It employs 1 to 10 people.

Where is PharmAlliance based?

PharmAlliance is headquartered in Ahmedabad, India, in the Asia region.

How does PharmAlliance make money?

Five revenue lines are on record. Regulatory Affairs Consulting is the primary driver. The others are facility Design and Project Services, business Development Consulting, training and Education and preclinical/Clinical/Bioequivalence Studies Support.

Who are PharmAlliance's main competitors?

Broad incumbents on record are Parexel International, ICON plc and IQVIA. Direct peers are ProPharma Group, Freyr Solutions, PharmaLex (Cencora), Cunesoft, Navitas Life Sciences and Arriello Group. Skillmine Technology Consulting is listed as a regional player.

Does PharmAlliance have an API?

No public API is recorded for PharmAlliance.

What industry is PharmAlliance in?

PharmAlliance's product category is Pharmaceutical Regulatory Consulting. Its primary akta.pro industry code is HLAGAKAI, Clinical Quality Assurance (GCP QA, TMF/QMS oversight), with a secondary code of HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC). Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales